Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Challenges for the study of disease in the 21st century • Characterise the function of every gene in the mammalian genome Genome • Generate mutations in every gene in the mouse genome Function • Characterise the phenotype of every mutant mice • Identify models of human disease Disease European Mouse Programmes • EUCOMM • Developing mouse mutants for most of the genes in the mouse genome • EUMORPHIA • Development and standardisation of mouse phenotyping platforms • EUMODIC - European Mouse Disease Clinic • Undertake a major pilot programme to utilise standardised phenotyping platforms for the analysis of a large number of mouse mutants Challenges for the study of disease in the 21st century • Characterise the function of every gene in the mammalian genome Genome • Generate mutations in every gene in the mouse genome Function • Characterise the phenotype of every mutant mice • Identify models of human disease Disease European Mouse Programmes • EUCOMM 2006-2009 • European Conditional Mouse Mutagenesis program • Major Participants - GSF, Sanger, Univ. Frankfurt, Max Planck, Berlin, Harwell, Univ. Dresden, Strasbourg, CNR & EMBL, Monterotondo, RZPD • 20,000 gene trap and targeted null/conditional ES lines library archived at RZPD, Heidelberg for distribution • 320 mouse lines generated and re-archived for distribution to the community • 20 new Cre expressing mouse strains generated • Complementary programmes in Canada - NorCOMM (underway), and US - KOMP (RFA) The European Conditional Mouse Mutagenesis Program 1. 2. 3. 4. 5. GSF National Center, Munich, Germany W. Wurst (coordinator), Hrabe de Angelis Wellcome Trust Sanger Institute, Hinxton, UK A. Bradley (coordinator), W. Skarnes, P. Liu University Frankfurt, Germany H. von Melchner Max-Planck-Institute of Molecular Genetics, Berlin, Germany P. Ruiz University Dresden, Germany F. Stewart EUCOMM 6. Gene Bridges, Dresden, Germany G. Stevens 7. Institute Clinique de la Souris (ICS), Strasbourg, France P. Chambon 8. EMBL, Monterotondo, Italy N. Rosentahl 9. Medical Research Council, Harwell, UK S. Brown 10. National Research Council, Monterotondo, Italy G. Tocchini-Valentini 11. German Rsesource Center of Genome Research (RZPD), Heidelberg B. Korn European Mouse Programmes • EUCOMM 2006-2009 • European Conditional Mouse Mutagenesis program • Major Participants - GSF, Sanger, Univ. Frankfurt, Max Planck, Berlin, Harwell, Univ. Dresden, Strasbourg, CNR & EMBL, Monterotondo, RZPD • 20,000 gene trap and targeted null/conditional ES lines library archived at RZPD, Heidelberg for distribution • 320 mouse lines generated and re-archived for distribution to the community • 20 new Cre expressing mouse strains generated • Complementary programmes in Canada - NorCOMM (underway), and US - KOMP (RFA) Challenges for the study of disease in the 21st century • Characterise the function of every gene in the mammalian genome Genome • Generate mutations in every gene in the mouse genome Function • Characterise the phenotype of every mutant mice • Identify models of human disease Disease Challenges of Phenotyping • Developing a comprehensive phenotyping platform able to deliver phenotypic information for all body systems • Standardising phenotyping protocols so that we can share and compare phenotype data from mouse genetics centres throughout the world The importance of standardisation • Better reproducibility of test outcome Across Time • Better comparability of test outcome Across Labs • Sharing of phenome results Unified Database Eumorphia Phenotype screens for mice Developing an integrated platform EUMORPHIA - the consortium MRC Mammalian Genetics Unit, UK IGBMC, Strasbourg, France EMBL Monterotondo, Italy MRC Human Genetics Unit, UK CNR-IBC, Monterotondo, Italy MRC Functional Genetics, UK Karolinska, Stockholm, Sweden ANIMAGE, Lyon, France UNIL-IBA, Lausanne, Switzerland CNG/CNRS Paris, France UNIGE, Geneva, Switzerland GSF, Munich, Germany Sanger Institute, Hinxton, UK GBF, Braunschwieg, Germany CNIO, Madrid, Spain NKI, Amsterdam, Netherlands Univ. Manchester, UK 18 centres across Europe Phenotyping - Workpackages Standardisation - animal handling First-line phenotyping European Mouse Phenotyping Resource for Standardised Screens EMPReSS Clinical Chemistry/Haematology Cardiovascular Renal systems Hormonal/metabolic Central, peripheral nervous system, Allergy and infection muscle Behaviour and cognition Imaging Necropsy, pathology, histology Sensory systems Pulmonary Cancer Bone, Cartilage Expression analysis What is EMPReSS? • European Mouse Phenotyping Resource for Standardised Screens • The EMPReSS provides a platform for the systematic and standardised primary characterisation of mouse mutant models • It is a comprehensive database of validated SOPs for systematic screens and tests that allows us to describe the phenotype of a mouse Working groups established SOPs discussed and drafted Validation between centres Discussion of validation results Revision of SOPs Revalidation between centres Review of SOPs by EMPReSS resource team Review and sign-off by Eumorphia scientist outside working group Additional validation between centres Inbred strains for validation BALB/cByJ (+ BALB/cAnN) AnN ENU mutagenesis at Harwell C57BL/6J (+ C57BL/6N) C3H/HeBFeJ (+ C3H/HeN) FeJ ENU mutagenesis at GSF/HeN at Harwell 129/SvPas (+ 129S6/SvEvTac) EMPReSS to date • WP groups established March 2003 • All relevant WPs have contributed • Over 150 SOPs and associated documents and annexes Global % PPI Open field % Centre Time 35 100 80 60 40 20 0 30 25 20 15 10 5 0 35 30 C57BL/6 25 20 15 10 C3HeH 5 0 40 BALB/c 35 30 25 20 129/Sv 15 10 5 0 15 12 9 6 3 0 1st round validation results 100 80 60 40 20 0 100 80 60 40 20 0 100 80 60 40 20 0 CNR GSF MRC ICS European Mouse Programmes • EUMORPHIA 2003-2006 • European Consortium to develop and standardise mouse phenotyping platforms - 18 centres across Europe • Over 150 SOPs developed and validated across laboratories in Europe • EMPReSS database, European Mouse Phenotyping Resource for Standardised Screens www.eumorphia.org • EuroPhenome database - phenotype validation data on inbred strains • Nature Genetics, November 2005 Challenges for the study of disease in the 21st century • Characterise the function of every gene in the mammalian genome Genome • Generate mutations in every gene in the mouse genome Function • Characterise the phenotype of every mutant mice • Identify models of human disease Disease European Mouse Programmes • EUMODIC 2007-2010 • European Mouse Disease Clinic - apply EMPReSS protocols to phenotyping of lines from EUCOMM • 650 lines from EUCOMM phenotyped through a subset of primary EMPReSS protocols - EMPReSSslim • 4 mouse clinics (Harwell, GSF, Sanger, Strasbourg) will carry out the primary phenotyping • Subsets of lines will be distributed to a network of secondary phenotyping centres for in-depth investigation • Data deposited to EuroPhenome database Beyond Eumorphia - EUMODIC 650 mouse lines Primary Phenotyping EMPReSSslim Refinement of SOPs Additional validation Mouse clinics GSF, Munich ICS, Strasbourg MRC, Harwell Sanger, Hinxton Secondary Phenotyping Bioinformatics Statistical analysis Community Databases Specialist Centres Development of new technologies EUCOMM 8 weeks 9 weeks 10 weeks Dysmorphology Calorimetry Clinical Chemistry 10 10 Dysmorphology / Blood / Metabolism 10 10 14 weeks 12 weeks Simplified IPGTT 10 10 10 10 Haematology Repeat Chemistry 10 10 Pipeline 1 Bone X ray DEXA 10 10 3 3 FACS analysis of peripheral blood cells Allergy / Immune 10 10 Immunoglobin concentration EMPReSSslim 10 10 M ANP Cardio 13 weeks Non-invasive Blood Pressure 10 10 14 weeks Echo Cardiography 10 10 10 10 8 weeks Open field 10 10 Sensory / Behaviour Modified SHIRPA 10 10 Grip Strength 10 10 Pipeline 2 9 weeks Acoustic Startle 10 10 Tail flick 10 10 10 weeks Tail suspension 10 10 Y-maze 10 10 Elevated Platform 10 10 Swim Ability 10 10 10 Number of males 10 Number of females 12 weeks Opthalmoscope & Slit Lamp 5 5 Beyond Eumorphia - EUMODIC 650 mouse lines Primary Phenotyping EMPReSSslim Refinement of SOPs Additional validation Mouse clinics GSF, Munich ICS, Strasbourg MRC, Harwell Sanger, Hinxton Secondary Phenotyping Bioinformatics Statistical analysis Community Databases Specialist Centres Development of new technologies EUCOMM Challenges for the study of disease in the 21st century • Characterise the function of every gene in the mammalian genome Genome • Generate mutations in every gene in the mouse genome Function • Characterise the phenotype of every mutant mice • Identify models of human disease Disease EUMORPHIA - the consortium MRC Mammalian Genetics Unit, UK IGBMC, Strasbourg, France EMBL Monterotondo, Italy MRC Human Genetics Unit, UK CNR-IBC, Monterotondo, Italy MRC Functional Genetics, UK Karolinska, Stockholm, Sweden ANIMAGE, Lyon, France UNIL-IBA, Lausanne, Switzerland CNG/CNRS Paris, France UNIGE, Geneva, Switzerland GSF, Munich, Germany Sanger Institute, Hinxton, UK GBF, Braunschwieg, Germany CNIO, Madrid, Spain NKI, Amsterdam, Netherlands Univ. Manchester, UK 18 centres across Europe